Style | Citing Format |
---|---|
MLA | Shafeghat M, et al.. "A Novel Homozygous Rag1 Mutation Is Associated With Severe Combined Immunodeficiency and Neurological Presentations." Allergologia et Immunopathologia, vol. 49, no. 4, 2021, pp. 91-97. |
APA | Shafeghat M, Esmaeilzadeh H, Sadeghalvad M, Rayzan E, Zoghi S, Shahkarami S, Heredia RJ, Krolo A, Boztug K, Rezaei N (2021). A Novel Homozygous Rag1 Mutation Is Associated With Severe Combined Immunodeficiency and Neurological Presentations. Allergologia et Immunopathologia, 49(4), 91-97. |
Chicago | Shafeghat M, Esmaeilzadeh H, Sadeghalvad M, Rayzan E, Zoghi S, Shahkarami S, Heredia RJ, Krolo A, Boztug K, Rezaei N. "A Novel Homozygous Rag1 Mutation Is Associated With Severe Combined Immunodeficiency and Neurological Presentations." Allergologia et Immunopathologia 49, no. 4 (2021): 91-97. |
Harvard | Shafeghat M et al. (2021) 'A Novel Homozygous Rag1 Mutation Is Associated With Severe Combined Immunodeficiency and Neurological Presentations', Allergologia et Immunopathologia, 49(4), pp. 91-97. |
Vancouver | Shafeghat M, Esmaeilzadeh H, Sadeghalvad M, Rayzan E, Zoghi S, Shahkarami S, et al.. A Novel Homozygous Rag1 Mutation Is Associated With Severe Combined Immunodeficiency and Neurological Presentations. Allergologia et Immunopathologia. 2021;49(4):91-97. |
BibTex | @article{ author = {Shafeghat M and Esmaeilzadeh H and Sadeghalvad M and Rayzan E and Zoghi S and Shahkarami S and Heredia RJ and Krolo A and Boztug K and Rezaei N}, title = {A Novel Homozygous Rag1 Mutation Is Associated With Severe Combined Immunodeficiency and Neurological Presentations}, journal = {Allergologia et Immunopathologia}, volume = {49}, number = {4}, pages = {91-97}, year = {2021} } |
RIS | TY - JOUR AU - Shafeghat M AU - Esmaeilzadeh H AU - Sadeghalvad M AU - Rayzan E AU - Zoghi S AU - Shahkarami S AU - Heredia RJ AU - Krolo A AU - Boztug K AU - Rezaei N TI - A Novel Homozygous Rag1 Mutation Is Associated With Severe Combined Immunodeficiency and Neurological Presentations JO - Allergologia et Immunopathologia VL - 49 IS - 4 SP - 91 EP - 97 PY - 2021 ER - |